By Andrew Dunn | 28 October 2020
BUSINESS INSIDER — Executives in charge of biotech and pharmaceutical companies working on coronavirus treatments and vaccines have raked in more than $1 billion by selling stock, Business Insider has found.
Shares of the companies they helm have soared this year, fueled by investors eager to reap a windfall from combating the pandemic. The executives and board members have benefited from the market’s enthusiasm by selling stock and exercising options. […]